Bringing innovative mRNA therapies and vaccines to patients requires more than optimized development and manufacturing processes. Success depends on a coordinated strategy that addresses everything from raw materials and production workflows to packaging, labeling, and logistics considerations that support product quality and commercialization.
Developers must navigate complex manufacturing, formulation, supply chain, and regulatory challenges while ensuring products remain stable, compliant, and efficiently distributed. Aligning mRNA development strategies with effective packaging and logistics planning can help reduce risk, improve operational efficiency, and create scalable pathways to market.
Discover practical approaches for advancing mRNA programs and strengthening packaging, labeling, and logistics operations in this edition of the Outsourced Pharma Capabilities Update. Watch the presentations below to gain valuable insights for your next development and commercialization initiative.
Recent Sessions Available On-Demand
Nanoparticles & Solid Dose Formulation – September 2026
Cell Line Development – August 2026
Large Molecule & Fill/Finish – August 2026
Gene Therapy – August 2026
Upcoming OPCU Topics & Times
Driving Biologics Manufacturing Innovation | 10/27/2026, AM Session
Fill/Finish Excellence | 10/27/2026, PM Session
Advancing Drug Substance Manufacturing | 10/28/2026, AM Session
Small Molecule Drug Product Innovation | 10/28/2026, AM Session
Enabling Success In Cell & Gene Therapy | 10/29/2026, AM Session
Advancing Analytical Capabilities | 10/29/2026, PM Session
Access more on-demand OPCU recordings and upcoming sessions here.
